The present invention provides dihydroorotate dehydrogenase inhibitors, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorders wherein the inhibition of Dihydroorotate dehydrogenase is known to show beneficial effect.
本发明提供了二
氢乳酸脱氢酶抑制剂、其制备方法、含有它们的药物组合物以及治疗、预防和/或改善已知抑制二
氢乳酸脱氢酶对某些疾病或疾病症状具有有益作用的方法。